Cargando…
Ocular Gene Therapy with Adeno-associated Virus Vectors: Current Outlook for Patients and Researchers
In this “Perspective”, we discuss ocular gene therapy – the patient's perspective, the various strategies of gene replacement and gene editing, the place of adeno-associated virus vectors, routes of delivery to the eye and the remaining question - “why does immunity continue to limit efficacy?”...
Autores principales: | Casey, Geoffrey A., Papp, Kimberly M., MacDonald, Ian M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PUBLISHED BY KNOWLEDGE E
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431728/ https://www.ncbi.nlm.nih.gov/pubmed/32864069 http://dx.doi.org/10.18502/jovr.v15i3.7457 |
Ejemplares similares
-
Small scale adeno-associated virus-vector production for preclinical gene delivery based on chloroform precipitation
por: Davidsson, Marcus, et al.
Publicado: (2021) -
Soluble interleukin 23 receptor gene therapy with adeno-associated vectors for the treatment of multiple sclerosis
por: Edo, Ángel, et al.
Publicado: (2017) -
Outlook on Thailand's Genomics and Computational Biology Research and Development
por: Tongsima, Wannipha, et al.
Publicado: (2008) -
Sigma-1 receptor and neuroprotection: current outlook and potential therapeutic effects
por: Li Volti, Giovanni, et al.
Publicado: (2016) -
Heparan sulfate proteoglycans and heparanases in Alzheimer's disease: current outlook and potential therapeutic targets
por: Lorente-Gea, Laura, et al.
Publicado: (2017)